Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Diggs, Charalett
NCT05521191: A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney Disease	Recruiting	1	70	US	RGLS8429, Placebo	Regulus Therapeutics Inc.	Autosomal Dominant Polycystic Kidney Disease, ADPKD, Polycystic Kidney, Autosomal Dominant	04/25	06/25
NCT01873235: PKD Clinical and Translational Core Study	Recruiting	N/A	350	US		University of Maryland, Baltimore, National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Polycystic Kidney Disease	06/27	06/27
Ross, Briget
NCT05521191: A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney Disease	Recruiting	1	70	US	RGLS8429, Placebo	Regulus Therapeutics Inc.	Autosomal Dominant Polycystic Kidney Disease, ADPKD, Polycystic Kidney, Autosomal Dominant	04/25	06/25
Helland, Ryan
POSITANO, NCT05281328 / 2021-003764-27: A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD	Active, not recruiting	2/3	71	Europe, US	CAM2029, octreotide subcutaneous depot, Placebo	Camurus AB, Camurus AB	Polycystic Liver Disease	02/25	08/27
NCT05521191: A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney Disease	Recruiting	1	70	US	RGLS8429, Placebo	Regulus Therapeutics Inc.	Autosomal Dominant Polycystic Kidney Disease, ADPKD, Polycystic Kidney, Autosomal Dominant	04/25	06/25